A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients

Summary

This is a phase 4, randomized, double-blind, multicenter clinical trial to evaluate the efficacy and safety of YMC026 in respiratory disease patients with cough and sputum as the main symptoms

Timeline

Start

2017-10-27

Primary completion

2018-04-11

Completion

2018-10-30

Drugs

Indications